Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents : Recent Advances
Supramolecular peptide hydrogels have many important applications in biomedicine, including drug delivery applications for the sustained release of therapeutic molecules. Targeted and selective drug administration is often preferential to systemic drug delivery, as it can allow reduced doses and can avoid the toxicity and side-effects caused by off-target binding. New discoveries are continually being reported in this rapidly developing field. In this review, we report the latest developments in supramolecular peptide-based hydrogels for drug delivery, focusing primarily on discoveries that have been reported in the last four years (2018-present). We address clinical points, such as peptide self-assembly and drug release, mechanical properties in drug delivery, peptide functionalization, bioadhesive properties and drug delivery enhancement strategies, drug release profiles, and different hydrogel matrices for anticancer drug loading and release.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Gels (Basel, Switzerland) - 8(2022), 11 vom: 01. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oliveira, Carlos B P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomaterials |
|---|
| Anmerkungen: |
Date Revised 26.11.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/gels8110706 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348682247 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348682247 | ||
| 003 | DE-627 | ||
| 005 | 20231226040832.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/gels8110706 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1162.xml |
| 035 | |a (DE-627)NLM348682247 | ||
| 035 | |a (NLM)36354614 | ||
| 035 | |a (PII)706 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oliveira, Carlos B P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents |b Recent Advances |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.11.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Supramolecular peptide hydrogels have many important applications in biomedicine, including drug delivery applications for the sustained release of therapeutic molecules. Targeted and selective drug administration is often preferential to systemic drug delivery, as it can allow reduced doses and can avoid the toxicity and side-effects caused by off-target binding. New discoveries are continually being reported in this rapidly developing field. In this review, we report the latest developments in supramolecular peptide-based hydrogels for drug delivery, focusing primarily on discoveries that have been reported in the last four years (2018-present). We address clinical points, such as peptide self-assembly and drug release, mechanical properties in drug delivery, peptide functionalization, bioadhesive properties and drug delivery enhancement strategies, drug release profiles, and different hydrogel matrices for anticancer drug loading and release | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a biomaterials | |
| 650 | 4 | |a cancer therapy | |
| 650 | 4 | |a controlled release | |
| 650 | 4 | |a drug delivery | |
| 650 | 4 | |a hydrogel | |
| 650 | 4 | |a peptide | |
| 650 | 4 | |a smart materials | |
| 650 | 4 | |a stimuli-responsive | |
| 650 | 4 | |a supramolecular | |
| 700 | 1 | |a Gomes, Valéria |e verfasserin |4 aut | |
| 700 | 1 | |a Ferreira, Paula M T |e verfasserin |4 aut | |
| 700 | 1 | |a Martins, José A |e verfasserin |4 aut | |
| 700 | 1 | |a Jervis, Peter J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gels (Basel, Switzerland) |d 2014 |g 8(2022), 11 vom: 01. Nov. |w (DE-627)NLM273273515 |x 2310-2861 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2022 |g number:11 |g day:01 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/gels8110706 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2022 |e 11 |b 01 |c 11 | ||